Drug Trial Radar · NCT03167905
CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery)
Last checked: Nov 19, 2026Latest source record: Aug 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
881
Actual
Start
Jun 15, 2017
Primary completion
Jul 19, 2021
Study completion Dec 31, 2027
Sponsor
- Lead sponsor
- KK Women's and Children's HospitalGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- First posted
- May 30, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 21 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Postnatal depression affects about 10-15% of women after childbirth. Approximately 3-5% of women experience a moderate-to-severe depression that requires medical attention. This study aims to investigate the implication of pain relief choice in reducing the postnatal depression of women who deliver their babies.
Conditions
- Depression, Postpartum
- Analgesia, Obstetrical
- Anesthesia, Obstetrical
Interventions
Epidural delivery systemDevice
Epidural delivery system for maintenance of labour epidural analgesia using 0.1% ropivacaine (amide local anaesthetic) with 2mcg/ml fentanyl (opioid) as maintenance solution.
EntonoxDrug
Entonox will be given upon request in non-epidural group.
MeperidineDrug
Intramuscular pethidine (75mg/1.5ml) will be given upon request in non-epidural group.
UltivaDrug
Intravenous patient controlled remifentanil (20-40mcg/ml) is only given when the patient rejects or cannot receive pethidine and entonox in non-epidural group..
FentanylDrug
Epidural delivery system for maintenance of labour epidural analgesia using 0.1% ropivacaine (amide local anaesthetic) with 2mcg/ml fentanyl (opioid) as maintenance solution.
RopivacaineDrug
Epidural delivery system for maintenance of labour epidural analgesia using 0.1% ropivacaine (amide local anaesthetic) with 2mcg/ml fentanyl (opioid) as maintenance solution.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The incidence of major postnatal depression in both groupsTime frame: 6-10 weeks after delivery
- The incidence of (clinically significant, probable) postnatal depression in both groupsTime frame: 6-10 weeks after delivery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
KK Women's and Children's Hospital
Singapore, Singapore
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.